INCR | InterCure Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.4400 - 1.6000
52 Week Range	1.1700 - 3.72
Beta	0.82
Implied Volatility	586.85%
IV Rank	100.00%
Day's Volume	294,433
Average Volume	34,652
Shares Outstanding	45,765,400
Market Cap	68,190,446
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2019-01-28

Valuation
Profitability
Growth
Health
P/E Ratio	-3.92
Forward P/E Ratio	N/A
EPS	-0.38
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	270
Country	Israel
Website	INCR

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

INCR's peers: ANIP, FLGC, AYRWF, VRNOF, TLLTF, LOWLF, VEXTF, SSIC, COLL, PAHC, EGRX, RGC, DLTNF, RAMMF, CVGRF, BHHKF, SPBBF, PBH, PCRX, IXHL, PRFX

*Chart delayed

Analyzing fundamentals for INCR we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see INCR Fundamentals page.

Watching at INCR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INCR Technicals page.